Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-12

FDA Approved: ROSUVASTATIN — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved the supplemental application for rosuvastatin from Accord Healthcare Inc., extending approval for the generic rosuvastatin product. This is a regul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)

Snippet

SUPPL AP for ROSUVASTATIN (ROSUVASTATIN)